Please assess the completion status of the following clinical trial:

Trial Title: Simvastatin Therapy in Women With Polycystic Ovary Syndrome.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* PCO - ESHRE/ASRM criteria: oligomenorrhea (\<8 spontaneous menses per year) and hyperandrogenism (hirsutism or acne) or hyperandrogenemia (testosterone \>70ng/dl)~* Normal prolactin, TSH, 17-OH progesterone~* No evidence of androgen producing malignancy, Cushing's syndrome or acromegaly~* Age 18-40~* Reliable use of birth control pill for at least 3 months and no plans of pregnancy~Exclusion Criteria:~* Elevated creatinine kinase above 2 times upper limit of normal or liver enzymes (transaminases) above 2 times of upper limit of normal~* Use of any of the following medications: cyclosporine, fibrates, niacin, antifungal agents, macrolide antibiotics.~* Use of oral contraceptives and other steroid hormones 3 months prior to the study~* Contraindications to oral contraceptives

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).